ArticleOncology letters2018

Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate.

Yongjian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.